Clinical trial
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in…
NCT00215527 · Patricia I. Dickson, M.D., Other · Terminated
Key facts
| NCT number | NCT00215527 |
|---|---|
| Title | Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I |
| Official title | A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I |
| Lead sponsor | Patricia I. Dickson, M.D., Other |
| Collaborators | The Ryan Foundation University of California, Los Angeles FDA Office of Orphan Products Development U.S. Fed |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Mucopolysaccharidosis I, Lysosomal Storage Diseases, Spinal Cord Compression |
| Intervention type | Drug |
| Interventions | laronidase |
| Enrollment | 4 |
| Start date | Nov 1, 2005 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 21, 2013 |
| Countries | Finland, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: